Double blind placebo controlled pilot trial of memantine for cognitive impairment in multiple sclerosis.
Phase of Trial: Phase II/III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders; Multiple sclerosis
- Focus Therapeutic Use
- 01 Jun 2010 Results have been published in Multiple Sclerosis.
- 02 May 2009 Primary endpoint results presented at the 61st Annual Meeting of the American Academy of Neurology
- 02 May 2009 Status change from recruiting to completed